Sponsors using a single-source outsourcing partner could potentially save up to $45m through reduced time to market, according to a recent Tufts study.
Patheon is “better positioned” to serve clients following the Thermo Fisher Scientific Inc. acquisition, says CDMO president, whose initial focus will be integration.
The laboratories will participate in oncology-focused clinical trials as the program’s preferred partners and will be among the first to access Thermo Fisher’s pipeline of novel platforms and assays.
Patheon NV has announced it will spend $45m to expand and enhance its manufacturing network citing customer demand for more reliable, flexible and cost-efficient supply chains.
Chinese authorities have given Thermo Fisher Scientific the green light to buy Life Technologies on the condition it discounts certain products sold in the coutry.
Proposed changes to USP chapters 232 and 233 on trace impurities would increase drug industry use of automated analysis, creating “huge number” of potential new customers says Thermo Fisher Scientific.
Japanese researchers look set to have another option for biomarker analysis, after Thermo Fisher Scientific unveils plans for Tokyo research laboratory unit.
US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.
Thermo Fisher Scientific saw revenues for the third quarter of 2007
rise to $2.4bn (€1.7bn) with its Analytical Technologies division
growing 12 per cent with quarterly sales of $1.04bn.
LabTechnologist.com brings you an exclusive interview with Greg
Herrema - president of the Scientific Instruments division of
Thermo Fisher Scientific.
Thermo Fisher Scientific and Sartorius have signed a supply
agreement continuing the relationship between Sartorius and
Thermo's recently acquired TC Tech.
Fisher Scientific has reported a second-quarter pre-tax profit jump
of 31 per cent to $146.1m (€113.4m), reflecting the success of
recent acquisitions and operating initiatives.
Thermo Electron announces the launch of its chromatography data
system (CDS), which provides enhancements in data integration with
laboratory information management systems (LIMS) for improved
laboratory productivity.
Pharmaceutical companies will be able to reduce their polymorph and
crystal analysis workload in their drug discovery laboratories
after Thermo Electron upgraded its array automation software for
Raman spectrometers.
